Cargando…
Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis
BACKGROUND: Hepatocellular carcinoma (HCC) represents the sixteenth most frequent cancer in Argentina. The rise of new therapeutic modalities in intermediate-advanced HCC opens up a new paradigm for the treatment of HCC. AIM: To describe real-life treatments performed in patients with intermediate-a...
Autores principales: | Piñero, Federico, Marciano, Sebastián, Fernández, Nora, Silva, Jorge, Anders, Margarita, Zerega, Alina, Ridruejo, Ezequiel, Romero, Gustavo, Ameigeiras, Beatriz, D’Amico, Claudia, Gaite, Luis, Bermúdez, Carla, Reggiardo, Virginia, Colombato, Luis, Gadano, Adrián, Silva, Marcelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658387/ https://www.ncbi.nlm.nih.gov/pubmed/31367160 http://dx.doi.org/10.3748/wjg.v25.i27.3607 |
Ejemplares similares
-
Fatty liver disease, an emerging etiology of hepatocellular carcinoma in Argentina
por: Piñero, Federico, et al.
Publicado: (2018) -
Hepatitis C in Argentina: epidemiology and treatment
por: Gaite, Luis Alejandro, et al.
Publicado: (2014) -
Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study
por: Lei, Xue-Fen, et al.
Publicado: (2018) -
Fat clearance and conventional fixation identified ypN0 rectal cancers following intermediate neoadjuvant radiotherapy have similar long-term outcomes
por: Chen, Nan, et al.
Publicado: (2019) -
Risk factors for acute kidney injury after partial hepatectomy
por: Bredt, Luis Cesar, et al.
Publicado: (2017)